220 related articles for article (PubMed ID: 28415746)
1. Epigenetic up-regulation of ribosome biogenesis and more aggressive phenotype triggered by the lack of the histone demethylase JHDM1B in mammary epithelial cells.
Galbiati A; Penzo M; Bacalini MG; Onofrillo C; Guerrieri AN; Garagnani P; Franceschi C; Treré D; Montanaro L
Oncotarget; 2017 Jun; 8(23):37091-37103. PubMed ID: 28415746
[TBL] [Abstract][Full Text] [Related]
2. JHDM1B expression regulates ribosome biogenesis and cancer cell growth in a p53 dependent manner.
Penzo M; Casoli L; Pollutri D; Sicuro L; Ceccarelli C; Santini D; Taffurelli M; Govoni M; Brina D; Trerè D; Montanaro L
Int J Cancer; 2015 Mar; 136(5):E272-81. PubMed ID: 25273595
[TBL] [Abstract][Full Text] [Related]
3. JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes.
Frescas D; Guardavaccaro D; Bassermann F; Koyama-Nasu R; Pagano M
Nature; 2007 Nov; 450(7167):309-13. PubMed ID: 17994099
[TBL] [Abstract][Full Text] [Related]
4. Combined expression levels of KDM2A and KDM2B correlate with nucleolar size and prognosis in primary breast carcinomas.
De Nicola I; Guerrieri AN; Penzo M; Ceccarelli C; De Leo A; Trerè D; Montanaro L
Histol Histopathol; 2020 Oct; 35(10):1181-1187. PubMed ID: 32901907
[TBL] [Abstract][Full Text] [Related]
5. The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15(Ink4b).
He J; Kallin EM; Tsukada Y; Zhang Y
Nat Struct Mol Biol; 2008 Nov; 15(11):1169-75. PubMed ID: 18836456
[TBL] [Abstract][Full Text] [Related]
6. CxxC-ZF domain is needed for KDM2A to demethylate histone in rDNA promoter in response to starvation.
Tanaka Y; Umata T; Okamoto K; Obuse C; Tsuneoka M
Cell Struct Funct; 2014; 39(1):79-92. PubMed ID: 24553073
[TBL] [Abstract][Full Text] [Related]
7. KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia.
He J; Nguyen AT; Zhang Y
Blood; 2011 Apr; 117(14):3869-80. PubMed ID: 21310926
[TBL] [Abstract][Full Text] [Related]
8. A systematic study of the cellular metabolic regulation of Jhdm1b in tumor cells.
Yu X; Wang J; Wu J; Shi Y
Mol Biosyst; 2015 Jul; 11(7):1867-75. PubMed ID: 25877602
[TBL] [Abstract][Full Text] [Related]
9. JmjC-domain containing histone demethylase 1B-mediated p15(Ink4b) suppression promotes the proliferation of leukemic progenitor cells through modulation of cell cycle progression in acute myeloid leukemia.
Nakamura S; Tan L; Nagata Y; Takemura T; Asahina A; Yokota D; Yagyu T; Shibata K; Fujisawa S; Ohnishi K
Mol Carcinog; 2013 Jan; 52(1):57-69. PubMed ID: 22086844
[TBL] [Abstract][Full Text] [Related]
10. Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription.
Zheng Q; Fan H; Meng Z; Yuan L; Liu C; Peng Y; Zhao W; Wang L; Li J; Feng J
Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):897-904. PubMed ID: 30060056
[TBL] [Abstract][Full Text] [Related]
11. Mild Glucose Starvation Induces KDM2A-Mediated H3K36me2 Demethylation through AMPK To Reduce rRNA Transcription and Cell Proliferation.
Tanaka Y; Yano H; Ogasawara S; Yoshioka S; Imamura H; Okamoto K; Tsuneoka M
Mol Cell Biol; 2015 Dec; 35(24):4170-84. PubMed ID: 26416883
[TBL] [Abstract][Full Text] [Related]
12. The H3K4me3 histone demethylase Fbxl10 is a regulator of chemokine expression, cellular morphology, and the metabolome of fibroblasts.
Janzer A; Stamm K; Becker A; Zimmer A; Buettner R; Kirfel J
J Biol Chem; 2012 Sep; 287(37):30984-92. PubMed ID: 22825849
[TBL] [Abstract][Full Text] [Related]
13. Mammalian lysine histone demethylase KDM2A regulates E2F1-mediated gene transcription in breast cancer cells.
Rizwani W; Schaal C; Kunigal S; Coppola D; Chellappan S
PLoS One; 2014; 9(7):e100888. PubMed ID: 25029110
[TBL] [Abstract][Full Text] [Related]
14. FBXL10 contributes to the development of diffuse large B-cell lymphoma by epigenetically enhancing ERK1/2 signaling pathway.
Zhao X; Wang X; Li Q; Chen W; Zhang N; Kong Y; Lv J; Cao L; Lin D; Wang X; Xu G; Wu X
Cell Death Dis; 2018 Jan; 9(2):46. PubMed ID: 29352142
[TBL] [Abstract][Full Text] [Related]
15. [A CxxC domain that binds to unmethylated CpG is required for KDM2A to control rDNA transcription].
Tsuneoka M; Tanaka Y; Okamoto K
Yakugaku Zasshi; 2015; 135(1):11-21. PubMed ID: 25743893
[TBL] [Abstract][Full Text] [Related]
16. KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.
Tzatsos A; Paskaleva P; Ferrari F; Deshpande V; Stoykova S; Contino G; Wong KK; Lan F; Trojer P; Park PJ; Bardeesy N
J Clin Invest; 2013 Feb; 123(2):727-39. PubMed ID: 23321669
[TBL] [Abstract][Full Text] [Related]
17. Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model.
Zhao QY; Lei PJ; Zhang X; Zheng JY; Wang HY; Zhao J; Li YM; Ye M; Li L; Wei G; Wu M
Clin Epigenetics; 2016; 8():34. PubMed ID: 27034728
[TBL] [Abstract][Full Text] [Related]
18. Induction of co-inhibitory molecule CTLA-4 by human papillomavirus E7 protein through downregulation of histone methyltransferase JHDM1B expression.
Zhou Q; Chen L; Song Y; Ma L; Xiao P; Chen L; Zhen H; Han R; Chen X; Sun S; Wang T; Zhang B; Wang Q; Cheng H
Virology; 2019 Dec; 538():111-118. PubMed ID: 31590057
[TBL] [Abstract][Full Text] [Related]
19. Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer.
Liu H; Liu L; Holowatyj A; Jiang Y; Yang ZQ
Mol Carcinog; 2016 May; 55(5):977-90. PubMed ID: 26207617
[TBL] [Abstract][Full Text] [Related]
20. NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells.
Kottakis F; Foltopoulou P; Sanidas I; Keller P; Wronski A; Dake BT; Ezell SA; Shen Z; Naber SP; Hinds PW; McNiel E; Kuperwasser C; Tsichlis PN
Cancer Res; 2014 Jul; 74(14):3935-46. PubMed ID: 24853546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
